ESR1 and cancer: Reactome aggregation analysis (FDR < 0.01) showed that the red target group was mainly associated with four pathways: IL-4 and IL-13 signaling, ESR-mediated signaling, PI3K/AKT signaling in cancer, and signaling by VEGF.